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Herbal medicine has become an increasing popular therapeutic alternative





 water-soluble extract (SME) have been shown to possess anti-
oxidant and anti-inflammatory properties in vitro. However, the mechanism
of action and impact of SME on LPS-induced gene expression is still





B transcriptional activity and ICAM-1 gene
expression in rat IEC-18 cells. Chromatin immunoprecipitation assay dem-
onstrated that LPS-induced RelA recruitment to the ICAM-1 gene promoter




 kinase assay showed that SME
directly inhibits LPS induced Ik
 
B kinase (IKK) activity in IEC-18 cells. To
investigate the physiological relevance of SME inhibitory activity on NF-k
 
B
signalling, we used small intestinal explants and primary intestinal epithelial
cells derived from a transgenic mouse expressing the enhanced green fluores-














 phosphorylation in intestinal explants and primary IECs, respec-
tively. However, salvianolic acid B, an activate component of SME did not
inhibit NF-k
 
B transcriptional activity and Ik
 
B phosphorylation/degradation
in IEC-18 cells. These results indicate that SME blocks LPS-induced NF-k
 
B
signalling pathway by targeting the IKK complex in intestinal epithelial cells.
Modulation of bacterial product-mediated NF-k
 
B signalling by natural plant
extracts may represent an attractive strategy towards the prevention and





















Intestinal epithelial cells (IECs) are the first line of defense
against noxious intraluminal agents including microorgan-
isms and toxic antigens [1,2]. Among the potential stimuli of
IECs, bacteria and bacterial products (lipopolysaccharide
[LPS], peptidoglycans) are the most important due to their
high content in the intestinal lumen [1,3]. Although IECs are
less responsive to LPS than monocytes/macrophages,
numerous groups have shown that endotoxin triggers a
proinflammatory gene transcriptional program in some var-
ious IEC [4–9], including rat small intestinal cell line IEC-6
[1,10,11]. Moreover, immunohistochemistry analysis clearly
showed enhanced RelA phosphorylation in the intestinal
epithelium of bacteria-monoassociated gnotobiotic rats
[10]. Thus, luminal endotoxin may participate in various
intestinal inflammatory disorders by virtue of its ability to
trigger a complex gene program in the intestinal epithelium.
Modulation of bacteria and bacterial product-induced gene
expression in the intestine may have significant impact in
intestinal inflammatory disorders. The signalling events lead-




B activity and pro-inflammatory
gene expression require the participation of the toll-like
receptor (TLR)-4 and the coreceptors CD-14 and MD-2
[4,12,13]. Down-stream of TLR4 lies numerous kinases and
adapter proteins that control LPS signalling to various effec-









requires the recruitment of MyD88 (myeloid differentiation
primary response gene 88) and IRAK-1 (IL-1 receptor asso-
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vated kinase 1-binding protein) complex [13]. The signal




B kinase (IKK) complex, which phospho-












 at serine resi-









B and permits the nuclear





promoter elements and induction of proinflammatory gene
transcription [12]. A challenging task for the intestinal
immune system is to swiftly response to pathogenic micro-
organism while remaining tolerant to the high bacteria load
found in the intestine. Not surprisingly, dysregulated innate/
adaptive response to the host endogenous microflora is asso-
ciated with intestinal inflammatory disorders such as inflam-
matory bowel diseases (IBD). A common feature of patients
with IBD and of various experimental models of IBD is the
dysregulated production of numerous inflammatory media-









B is involved in the tran-
scriptional regulation of these various proinflammatory
molecules, there is a growing interest in targeting this signal-





lates the expression of ICAM-1, a cell surface glycoprotein
that plays a pivotal role in the recruitment of leucocytes at
the sites of intestinal inflammation. This adhesion molecule
is up-regulated in the inflamed intestinal mucosa [18–20].
Recent studies showed that a topically administered enema
formulation of ISIS 2302, an antisense inhibitor of ICAM-1,
improved the clinical symptoms in patients with mild to
moderately active distal ulcerative colitis and chronic unre-
mitting pouchitis, respectively [21,22]. An interesting




B activity in vivo is the
use of natural plant extracts. A growing segment of patients
with IBD already relied on alternative medicine, including




 Bunge, known as Danshen, has long
been used as a traditional oriental medicine for cardiovascu-




 extracts contain lipid-
soluble diterpene quinones (tanshinones) and water-soluble
phenolic acid derivatives such as salvianolic acid A, B and
lithospermic acid B [24,25]. Recent articles have shown that





trophil-endothelial adhesion [26], and salvianolic acid B











mediates its anti-inflammatory effects is not clear. We inves-









B signalling and proinflamma-
tory gene expression in IECs. We report that SME prevents









, and in small intestine explants and primary
IECs derived from a transgenic mice expressing the
enhanced green fluorescent protein (EGFP) under the tran-





















These findings suggest that SME represent a new plant






 water-soluble extract (SME) and 
salvianolic acid B (Sal B)
 




 were extracted with 70%
ethanol and the extract obtained was filtered and concen-
trated to obtain 8 : 1 powdered extract. This extract (Lot #
SLV 02210, Narula Research, Chapel Hill, NC, USA) which
contains water-soluble polyphenolic acids including salvian-
olic acids was dissolved in PBS to a final concentration of
50 mg/ml. Purified salvianolic acid B was purchased from Ivy
Fine Chemicals (Cherry Hill, NJ, USA) and was dissolved in
PBS to a final concentration of 20 mM.
 
Cell culture and treatment of IEC
 
The rat nontransformed small intestinal cell line IEC-18
(ATCC CRL 1589, Manassas, VA,USA) was used between
passages 5 and 15. Cells were grown as described previously
[11]. Cells were pretreated for 1 h with various concentra-




M) or with PBS
























 mice (BALB/c background) were used



























inducers, including LPS [28]. Animal experiments were per-
formed in accordance with the guidelines of the institutional
Animal Care and Use Committee of the University of North




RNA was isolated using Trizol (Invitrogen, Carlsbad, CA,




g of total RNA was reverse-transcribed as
described previously [29]. Real-time RT-PCR was performed
using an ABI Prism 7700 sequence detection system (Applied
Biosystems, Foster City, CA, USA) with specific primers for
rat ICAM-1. As an endogenous control, 18S ribosomal RNA
primers were used. All primers were designed by Primer
Express v2·0 (Applied Biosystems). The sequence of primers
used were as follows: rat ICAM-1 (forward primer) 5-CGGG
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(reverse primer) 5-CATTCTTGGCAAATGCTTTCG-3. PCR
was conducted using SYBR Green PCR Master Mix (Applied
Biosystems) according to the manufacturer’s instructions.
Thermal cycler conditions were as follows: one cycle of














specificity of the amplicon was tested via melting curve anal-
ysis. A serial dilution of an external standard (positive sam-
ples; LPS treated) was used to generate a calibration curve to
determine signal intensity of each sample according to their
threshold cycle. The amplifications were performed in trip-
licates and the data was normalized to the 18S ribosomal
subunit.
 











































 and Ad5wtNIK constructs were described pre-
viously [30]. The Ad5GFP containing GFP was used as a viral
negative control. The adenoviruses were washed off, and
fresh medium containing serum was added. Cells were pre-
treated with various concentration of SME or Sal B and then




g/ml) for 12 h. Cell extracts were
prepared using luciferase cell lysis buffer (PharMingen, San
Diego, CA, USA). Luciferase assays were performed using an
Lmax luminometer microplate reader (Molecular Devices,
Sunnyvale, CA, USA), and results were normalized for
extract protein concentrations measured with the Bio-Rad














g of protein was subjected to electrophoresis on 10%
SDS-polyacrylamide gels as described previously [11].






















































an enhanced chemiluminescence detection kit (Amersham
Biosciences, Arlington Heights, IL, USA).
 






g/ml)-pretreated IEC-18 cells were stimulated




g/ml) for 30 min, after which they were fixed
with 100% ice-cold methanol. RelA immunofluorescence
was performed as described previously [29]. Briefly, cells
were blocked with 10% nonimmune goat serum (NGS) for
30 min, then probed with rabbit anti-RelA Ab (Rockland,
Gilberville, PA, USA; diluted 1 : 200) in 10% NGS for
45 min, followed by rhodamine isothiocyanate-conjugated
goat antirabbit IgG Ab (Jackson ImmunoResearch, West
Grove, PA, USA; diluted 1 : 100) in 10% NGS for 30 min.
RelA was visualized with a fluorescent light microscope.
 
Chromatin immunoprecipitation (ChIP) assay
 





stimulated with LPS (10 mg/ml) for 30 min, washed in cold
PBS and fixed by adding formaldehyde to a final concentra-
tion of 1%. Nuclear extraction and chromatin immunopre-
cipitation were performed as described previously [10].
Briefly, cells were lysed after formaldehyde fixation in L1 lysis
buffer (50 mM Tris [pH 8·0], 2 mM EDTA, 0·1% Nonidet P-
40, and 10% glycerol) supplemented with protease inhibi-
tors. Nuclei were pelleted and resuspended in 300 ml of L2
lysis buffer (50 mM Tris [pH 8·0], 0·1% SDS, and 5 mM
EDTA). Chromatin was sheared by sonication (3 times for
10 s at one-fifth of maximum power), centrifuged, and
diluted in dilution buffer (50 mM Tris [pH 8·0], 5 mM
EDTA, 0·2 M NaCl, and 0·5% Nonidet P-40). Extracts were
precleared for 3 h with salmon sperm-saturated protein A/
G-agarose (ssProtein A/G). Immunoprecipitation was car-
ried out overnight at 4 ∞C using 5 ml of anti-phosphoserine
RelA (Cell Signalling). Immune complexes were collected
with ssProtein A/G for 30 min and washed three times in
washing buffer (20 mM Tris [pH 8·0], 0·1% SDS, 0·5 M
NaCl, 2 mM EDTA, and 1% Nonidet P-40) and once in 0·5
M LiCl, followed by three washes with TE buffer. Immune
complexes were extracted 3 times with 100 ml of extraction
buffer (TE buffer containing 2% SDS). DNA cross-links were
reverted by heating for 8 h at 65∞C. After proteinase K
(100 mg for 2 h) digestion, DNA was extracted with phenol/
chloroform and precipitated in ethanol. DNA isolated from
an aliquot of the total nuclear extract was used as a loading
control for the PCR (input control). PCR was performed
with total DNA (1 ml, input control) and immuno-
precipitated DNA (2 ml) using the following rat ICAM-1
promoter-specific primers: ICAM-1 promoter (forward
primer) 5-CTTCTCTCCCGGACTCTCCT-3 AND ICAM-1
(reverse primer) 5-ATGAGGGCTTCGGTATTTCC-3.
In vitro IkB kinase assay
IEC-18 cells were pretreated for 1 h with SME (500 mg/ml)
and then stimulated with LPS (10 mg/ml) for 20 min or
infected with Ad5wtNIK (m.o.i 50) for 16 h. IKK activity on
serine IkBa phosphorylation was determined by immuno-
complex kinase assay as described previously [29,30]. Briefly,
IEC-18 cells were lysed in Triton lysis buffer containing
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protease and phosphatase inhibitors and then cleared by
cenrifugation at 18 000 g for 10 min. Three hundred micro-
grams of whole cell extract were immunoprecipitated with
anti-IKKg (Santa Cruz Biotechnology)/protein-A beads and
the kinase reaction was performed by incubating 25 ml of
kinase buffer containing 20 mM Hepes (pH 7·7), 10 mM
MgCl2, 5 mM dithiothreitol, 50 mM ATP, and 5 mCi of [g-32P]
ATP (ICN) with GST-IkBa substrate (amino acid 1–54) for
30 min at 30 ∞C. Substrate proteins were resolved by gel elec-
trophoresis, and phosphate incorporation was assessed by
autoradiography and PhosphorImager analysis (Amersham
Biosciences).
Alternatively, the effect of SME on IKK activity was
directly measured. Immunoprecipitated IKK complexes
from LPS (10 mg/ml)-stimulated IEC-18 cells were incubated
with various concentrations of SME or control PBS vehicle
and the kinase reactions were performed as described above.
Cytotoxicity assay
IEC-18 cells were pretreated with various concentration of
SME and then stimulated with LPS. Cytotoxicity was mea-
sured using the LIVE/DEAD Viability/Cytotoxicity Kit
(Molecular Probes, Eugene, OR, USA) according to the man-
ufacturer’s specifications. Positive control dead cells were
generated by treating IEC-18 cells with methanol for 30 min.
Fluorescence in cell samples was measured with appropriate
excitation and emission filters using a SpectraMax Gemini
XS spectrofluorometer (Molecular Devices) according to the
manufacturer’s instructions.
Murine small intestinal explants and primary IEC study
Cis-NF-kBEGFP mice were euthanized, dissected and the
small intestines were flushed and sectioned into 2 cm
parts. The small intestinal explants were incubated in
RPMI-1640 with 10% FBS and antibiotics. The explants
were pretreated for 1 h with SME (500 mg/ml) and then
stimulated with LPS (10 mg/ml) for 12 h. The sections were
imaged using either a CCD camera in a light-tight imag-
ing box with a dual filtered light source and emission fil-
ters specific for EGFP (LT-99D2 Illumatools, Lightools
Research, Encinitas, CA, USA), or alternatively, scanned
using a PhosphorImager with fluorescence settings
(Typhoon 8600, Amersham Biosciences). Fluorescent
intensity was quantified by the densitometric analysis using
ImageQuant software ver 2·2.
To study SEM effects on primary intestinal epithelial cells,
the small intestine from Cis-NF-kBEGFP mice was sliced open
and washed 3 times in PBS and twice in 3 mM EDTA and
0·5 mM DTT (solution A). The small intestine was incu-
bated for 90 min at room temperature in solution A with
shaking, and then the resulting supernatant wase passed
over nylon filter. The cellular suspension was centrifuged,
washed, and resuspended in RPMI-1640 with 10% FBS and
antibiotics. Cells were pretreated for 1 h with SME (500 mg/
ml) and then stimulated with LPS (10 mg/ml) for various
times.
Statistical analysis
All data were expressed as the means for a series of
experiments ± SEM. Data were analysed by nonparametric t-
tests or Wilcoxon rank sum tests. A 2-tailed P-value of <0·05
was considered statistically significant.
Results
SME abrogates LPS-induced ICAM-1 mRNA expression 
and NF-kB transcriptional activity in IECs
We first evaluated the effects of SME on LPS-induced
ICAM-1 gene expression in the rat nontransformed intesti-
nal cell line IEC-18. Cells were pretreated with SME
(500 mg/ml) for 1 h, stimulated with LPS (10 mg/ml) for up
to 4 h and ICAM-1 gene expression was measured by real-
time RT-PCR using an ABI Prism 7700 sequence detection
system. As seen in Fig. 1a, LPS-induced ICAM-1 mRNA
expression is inhibited by SME treatment (64% and 49%
inhibition at 1 h and 4 h poststimulation, respectively). A
critical downstream effector pathway induced by LPS is the
NF-kB transcriptional system. Thus we next assessed
whether SME abrogates LPS-induced NF-kB transcriptional
activity using a luciferase reporter gene assay. As shown in
Fig. 1b, SME dose-dependently blocked LPS-induced NF-
kB transcriptional activity in IEC-18 cells. As expected, the
molecular inhibitory approach using Ad5IkBaAA and
Ad5dnIKKb blocked LPS-induced NF-kB activity in IEC-18
cells. To rule out the possibility that SME-mediated inhibi-
tion of LPS-induced gene expression is due to a cytotoxic
effect, we measured SME-induced cytotoxicity in LPS-
stimulated IEC-18 cells. SME-treated cells exhibited mini-
mal cytotoxicity as compared to methanol-treated control,
suggesting that the SME is not significantly altering cell via-
bility (Fig. 2).
SME blocks LPS-induced IkBa phosphorylation/
degradation and RelA nuclear translocation
To dissect the effect of SME on LPS-induced NF-kB signal
transduction, we determined the phosphorylation levels of
various down-stream signalling proteins involved in NF-kB
pathway using Western blot analysis. Figure 3a shows that
LPS induced IkBa phosphorylation (first panel) and trig-
gered IkBa degradation (second panel) in IEC-18 cells,
which are blocked in SME-pretreated cells (compared lanes 3
and 5 with lanes 2 and 4). As opposed, EGF-induced p38
phosphorylation is not inhibited in SME-treated cells
(Fig. 3b), suggesting that this botanical extract is not a pan
inhibitor of kinase activity.
J. S. Kim et al.
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Accordingly, SME significantly suppressed LPS-induced
RelA nuclear translocation in IEC-18 cells as determined by
immunofluorescence staining (Fig. 4). To evaluate the func-
tional impact of decreased nuclear RelA in SME-treated cells,
we carried out chromatin immunoprecipitation (ChIP)
analysis on the ICAM-1 gene promoter. IEC-18 cells were
stimulated with LPS (10 mg/ml) in the presence or absence of
SME (500 mg/ml), and RelA recruitment to the ICAM-1 pro-
moter region determined by PCR. As seen in Fig. 5, LPS-
induced RelA recruitment to the ICAM-1 gene promoter was
inhibited in SME treated cells, whereas similar levels were
amplified from the total pool of genomic DNA (input con-
trol). Taken together, SME blocks NF-kB signalling through
inhibition of IkBa phosphorylation/degradation, RelA
nuclear translocation and binding to the ICAM-1 gene
promoter.
SME directly inhibits LPS-induced IkB kinase activity in 
IECs
LPS-induced serine 32 and 36 IkBa phosphorylation is trig-
gered by activation of the IKK complex [23]. To determine
the impact of SME on IKK activity, we performed an in vitro
kinase assay. IEC-18 cells were pretreated with various doses
of SME (250 and 500 mg/ml), stimulated with LPS (10 mg/
ml) for 20 min and IKKg was immunoprecipitated, and then
kinase activity was measured using a GST-IkB (1–54) sub-
strate. As shown in Fig. 6a, SME (500 mg/ml) significantly
inhibited LPS-induced IKK activity in IEC-18 cells. Since the
MAP3K NF-kB-inducing kinase (NIK) participates in LPS-
induced IKK activity [31], we investigated the effect of SME
on NIK-induced NF-kB activation. In accordance with pre-
vious reports [30,32], adenoviral gene delivery of NIK
(Ad5wtNIK) strongly induced (>20-fold) NF-kB transcrip-
tional activity (Fig. 6b), which was significantly inhibited by
Fig. 1. Salvia miltiorrhizae extract (SME) abrogates LPS-induced 
ICAM-1 mRNA expression and NF-kB transcriptional activity. (a) IEC-
18 cells were pretreated with SME (500 mg/ml) for 1 h, and then stim-
ulated with LPS (10 mg/ml) for up to 4 h. Total RNA (1 mg) was 
extracted, reverse-transcribed, and amplified with an ABI Prism 7700 
sequence detection system using specific rat ICAM-1 primers. Relative 
quantification was performed by comparison of threshold cycle values 
of samples with 18S ribosomal RNA. (b) IEC-18 cells were infected for 
16 h with Ad5kB-LUC, and cells were coinfected for an additional 12 h 
with Ad5IkBaAA, Ad5dnIKKb, and control Ad5GFP (m.o.i. of 50). 
Cells were stimulated with LPS (10 mg/ml) for 12 h in the presence or 
absence of various concentrations of Salvia miltiorrhizae extract (SME). 
Cell extracts were prepared, luciferase assays were performed, and 
results were normalized to extract protein concentrations. Data are 
expressed as fold changes over control determined as the mean of three 
independent experiments measured in triplicate (values are mean ± 












































































Fig. 2. Salvia miltiorrhizae extract (SME) does not induce cytotoxicity 
in IECs. IEC-18 cells were pretreated with SME (500 mg/ml) for 1 h, and 
then stimulated with LPS (10 mg/ml) for 24 h. Simultaneous two-colour 
fluorescence determination of live and dead cells was carried out with 
two probes that measured two recognized parameters of cell viability: 
calcein AM for intracellular esterase activity and ethidium homodimers 
for plasma membrane integrity. Cells were incubated with methanol 
(100%) for 30 min to generate a positive control for cell death. Fluores-
cence in cell samples was measured with appropriate excitation and 
emission filters using a spectrofluorometer. Results are representative of 
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SME treatment. Since NIK directly activates the IKK com-
plex, this finding suggests that SME interferes with signalling
events proximal to NIK-IKK. We next tested whether SME
directly impact on IKK activity in IEC-18 cells by using a cell
free kinase assay system. SME (500 mg/ml) was added to LPS-
stimulated (20min) IKKg immunoprecipitated beads and
kinase activity was determined using a GST-IkB substrate. As
shown in Fig. 6c, LPS-induced IKK activity is blocked by
SME, suggesting that this extract directly blocks IKK activity
in IEC-18 cells.
SME inhibits LPS-induced NF-kB signalling in murine 
small intestinal explants and in primary IECs
To verify the physiological relevance of SME-mediated inhi-
bition of LPS-induced NF-kB signalling, we used small intes-
tinal explants derived from a transgenic mouse expressing
the EGFP under the transcriptional control of NF-kB cis-
elements (cis-NF-kBEGFP). We have shown that this mouse
displayed enhanced EGFP expression in numerous tissues
following induction of NF-kB signalling [28]. The small
intestine from cis-NF-kBEGFP was sectioned and pretreated
with SME for 1 h, and then stimulated with LPS for 12 h.
EGFP expression levels were determined using either a CCD
specific EGFP imaging camera or a PhosphorImager. LPS
induced EGFP expression level (64%) compared to unstim-
ulated intestinal explant, and was inhibited by 74% in SME-
treated explant (Fig. 7a,b).
To determine whether SME blocks LPS-induced NF-kB
signalling in primary IECs, we isolated IECs from the small
intestine of cis-NF-kBEGFP mice. SME blocked LPS-induced
IkBa phosphorylation in primary IECs in a manner similar
to that observed in IEC-18 cells (Fig. 7c). Altogether, these
finding indicate that SME inhibits LPS-induced NF-kB sig-
nalling pathway through blockade of IKK activity.
Salvianolic acid B does not inhibit LPS-induced NF-kB 
transcriptional activity and IkBa phosphorylation/
degradation in IECs
Salvianolic acid B, a phenolic constituent of SME, has been
showed to inhibit TNF-a induced ICAM-1 gene expression
in endothelial cells [4]. Thus, we next investigated whether
this compound could mediate SME inhibitory effect. As seen
in Fig. 8a, LPS-induced NF-kB transcriptional activity is not
blocked in salvianolic acid B-treated IEC-18 cells. Moreover,
LPS-induced IkBa phosphorylation (first panel) and IkBa
degradation (second panel) are not inhibited in salvianolic
acid B-treated IEC-18 cells (Fig. 8b) This indicates that
SME-mediated blockade of LPS-induced NF-kB activity is
independent of salvianolic acid B.
Discussion
In this study, we investigated the effect of the SME on LPS-
induced NF-kB signalling in IECs. We showed that SME
strongly inhibited LPS-induced NF-kB transcriptional activ-
ity and ICAM-1 gene expression. This effect was mediated
through direct inhibition of IKK activity, causing a strong
reduction of LPS-induced IkBa phosphorylation/degrada-
tion and RelA nuclear translocation. This was accompanied
by reduced RelA recruitment to the ICAM-1 gene promoter
in LPS-stimulated cells. To investigate the physiological rel-
evance of SME-mediated inhibition of NF-kB activity, we
used the cis-NF-kBEGFP transgenic mice recently engineered
in our laboratory [28]. This transgenic mouse allows the
dynamic assessment of NF-kB activity through measure-
ment of EGFP expression levels using specialized
fluorescence-detecting camera. Using this approach, we
demonstrate for the first time that SME blocks LPS-induced
EGFP expression levels, thus NF-kB activation in small intes-
Fig. 3. Salvia miltiorrhizae extract (SME) blocks LPS-induced IkBa 
phosphorylation/degradation. (a) IEC-18 cells were stimulated with 
LPS (10 mg/ml) for various times (0–30 min). Where indicated, IEC-18 
cells were pretreated for 1 h with SME (500 mg/ml). Total protein was 
extracted, and 20 mg of protein was subjected to SDS-PAGE followed by 
phospho-IkBa, IkBa, and b-actin immunoblotting using the ECL tech-
nique. Results are representative of three independent experiments. Veh, 
PBS vehicle. (b) IEC-18 cells were stimulated with EGF (10 ng/ml) for 
various times (0–60 min). Where indicated, IEC-18 cells were pretreated 
for 1 h with SME (500 mg/ml). Total protein was extracted, and 20 mg 
of protein was subjected to SDS-PAGE followed by phospho-p38, p38, 
and b-actin immunoblotting using the ECL technique. Results are rep-
resentative of three independent experiments. Veh, PBS vehicle.
Veh – SME – SME
 10 30 min
LPS
Veh – SME – SME
 15 60 min
EGF
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tine explants. Therefore, SME blocks LPS-induced NF-kB
activity both in cell lines and in primary intestinal epithelial
cells.
Enhanced EFGP expression in LPS-stimulated intestinal
explants is not a direct proof that intestinal epithelial cells are
responsible for this effect. Interestingly, we have shown that
intraperitoneal injection of LPS in cis-NF-kBEGFP transgenic
mice lead to increase EGFP accumulation mainly in the
duodenum [28]. Using immunohistochemistry and confocal
analysis, we have identified the EGFP positive cells as being
lamina propria mononuclear cells (monocytes and lympho-
cytes) and IEC, although the latter represent a weak fraction
of the total EGFP positive cells. Similarly, we showed here
that primary cells isolated from cis-NF-kBEGFP transgenic
mice displayed enhanced IkB phosphorylation in response
to LPS. SME inhibited LPS-induced IkB phosphorylation
suggesting that decreased EGFP expression levels in small
intestinal explants are partially due to decreased NF-kB sig-
nalling in IEC. Further work will be necessary to identify the
cells targeted by SME in vivo.
For centuries, natural plant extracts have been used as
remedies to treat numerous medical conditions in Eastern
countries. Although incorporation of natural plant extracts
as alternative medicine has been slow in the United States,
the past decade has seen a rapid user increase among the
population [33]. Indeed, a survey indicated that herbal med-
icine users have increased by more than 400% in the United
States between 1990 and 1997 [34], and 16% of prescription
drug users have taken natural products/supplements [35].
Despite this tremendous grow of herbal medicine users, lack
of empirical data showing efficacy, safety and mechanism of
action preclude their incorporation in mainstream medi-
cine. In this study, we demonstrate the efficacy and nontoxic
inhibitory effects of the water-soluble Salvia miltiorrhizae
extract on LPS-induced NF-kB signalling pathway in both
IEC and in an intestinal explant culture system. The water-
soluble extract of Salvia miltiorrhizae has been used clinically
in China to alleviate certain diseases including myocarditis
and myocardial infarction, cerebral vascular diseases, and
chronic hepatitis [23,36–38]. Since our data demonstrate
that water-soluble extract of Salvia miltiorrhizae blocks
innate signalling to NF-kB, this suggests that this extract may
be beneficial in treating inflammatory condition involving
dysregulated innate/adaptive immune response. Moreover,
considering that dysregulated NF-kB activation associates
with the development of IBD, SME may represent an attrac-
tive approach for the treatment/prevention of intestinal
inflammation. Further investigations are needed to docu-
ment the safety and efficacy of SME on treating colitis in
experimental models of intestinal inflammation.
In this study, we showed that the water-soluble fraction of
Salvia miltiorrhizae blocks LPS-induced IKK activity in IEC.
The hydrophilic fraction of Salvia miltiorrhizae contains
Fig. 4. Salvia miltiorrhizae extract (SME) inhibits LPS-induced RelA nuclear translocation. IEC-18 cells were pretreated with SME (500 mg/ml) for 
1 h, and then stimulated with LPS (10 mg/ml) for 30 min. RelA localization was visualized using an anti-RelA primary Ab followed by a rhodamine-
conjugated detection Ab. This immunofluorescence is representative of two independent experiments. Veh, PBS vehicle.
Veh LPS LPS+SME
Fig. 5. Salvia miltiorrhizae extract (SME) blocks LPS-induced NF-kB 
recruitment to the ICAM-1 promoter in IECs. IEC-18 cells were stimu-
lated with LPS for 30 min in the presence or absence of SME (500 mg/
ml), and ChIP assay was performed using an antiphospho-RelA Ab as 
described under ‘Materials and methods’. PCR was performed using 
specific primers for the rat ICAM-1 promoter. Results are representative 
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several natural phenolic compounds including salvianolic
acid A, salvianolic acid B, lithospermate B, rosmarinic acid,
protocatechualdehyde, protocatechuic acid, caffeic acid and
danshensu [25]. TNF-a-induced VCAM and ICAM-1
expression is inhibited in salvianolic acid B-treated human
aortic endothelial cells [27], which correlated with decrease
Fig. 6. Salvia miltiorrhizae extract (SME) directly inhibits LPS-induced 
IkB kinase activity in IECs. (a) IEC-18 cells were pretreated with SME 
(500 mg/ml) for 1 h, and then stimulated with LPS (10 mg/ml) for 
20 min. Whole cell extract was immunoprecipitated with anti-IKKg/
protein-A beads and the kinase reaction was performed using GST-IkB 
(1–54) as a substrate as described under ‘Materials and methods’. Sub-
strate protein was resolved by gel electrophoresis, and phosphate incor-
poration was assessed by autoradiography and PhosphorImager 
analysis. Coomassie Blue staining shows equal loading (lower blot). (b) 
IEC-18 cells were coinfected with Ad5kB-LUC and Ad5wtNIK in the 
presence or absence of SME (500 mg/ml). Luciferase assay was measured, 
and results were normalized for extract protein concentrations. Values 
are mean ± SEM. (c) To evaluate whether SME inhibits IKK directly, 
immunoprecipitated IKK from LPS-stimulated (20min) IEC-18 cells 
was aliquoted into kinase reaction buffer in presence of various concen-
trations of SME or PBS vehicle. IKK kinase assay was performed as 
described above. These results are representative of at least two indepen-







































Fig. 7. Salvia miltiorrhizae extract (SME) inhibits LPS-induced NF-kB 
signalling in murine small intestinal explants and in primary intestinal 
epithelial cells. (a) Small intestinal segments derived from cis-NF-kBEGFP 
mice were pretreated for 1 h with SME (500 mg/ml) and then stimulated 
with LPS (10 mg/ml) for 12 h. The segments were imaged using either a 
CCD camera with a filtered light source and emission filters specific for 
EGFP or alternatively, scanned using a PhosphorImager with fluores-
cence settings. (b) Fluorescence intensity was quantified by densitomet-
ric analysis using ImageQuant software ver 2·2. (c) Small intestinal 
epithelial cells isolated from cis-NF-kBEGFP mice were pretreated for 1 h 
with SME (500 mg/ml) and then stimulated with LPS (10 mg/ml) for 
various times. Cell extracts were obtained and IkB phosphorylation was 
analysed by Western blotting. Results are representative of at least two 
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expression of the p65 NF-kB subunit. Interestingly, we found
that salvianolic acid B did not inhibit LPS-induced NF-kB
transcriptional activity and IkBa phosphorylation/degrada-
tion in IEC-18 cells. Thus, the active component responsible
for SME-mediated inhibition in IEC remains to be identi-
fied. Further investigation will be necessary to identify a spe-
cific compound mediating IKK inhibition in water-soluble
fraction of Salvia miltiorrhizae. However, it should be
stressed that the biological activity of a natural plant extract
may be strikingly different from its isolated purified constit-
uent. Indeed, the complex mixture of compounds present in
numerous natural plant extracts are likely responsible for
their various biological activities, including additive and syn-
ergistic effects [39].
Cytokine and bacterial product signalling converge on the
IKK complex to trigger IkB phosphorylation and ultimately
NF-kB activity in numerous cell systems. Using adenoviral
gene delivery, we found that SME blocked NIK-induced NF-
kB transcriptional activity in IEC-18 cells, suggesting that
this extract mediates its suppressive effects downstream of
NIK. Since SME strongly blocked LPS-induced IKK activity
in IEC-18, this suggests that this extract mainly mediates its
effects through this kinase complex. This is in line with the
inhibitory effect of SME on IL-1b and TNF-a-induced
ICAM-1 gene expression (Kim and Jobin, unpublished
data), which all utilized IKK as a common signal transducer
to induce NF-kB activity. Thus, the anti-inflammatory activ-
ities of some natural plant extracts and pure constituents
may be mediated through IKK inhibition [40,41].
In conclusion, we show that SME abrogates LPS-induced
NF-kB signalling and proinflammatory gene expression in
intestinal epithelial cells through the direct inhibition of IKK
activity. Modulation of bacterial product-mediated NF-kB
signalling by natural plant extracts may represent an attrac-
tive strategy towards the prevention and treatment of intes-
tinal inflammation.
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